Associations - AR overexpression

BIOMARKER:

AR overexpression

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

AR overexpression AR overexpression	Triple Negative Breast Cancer Triple Negative Breast Cancer	TAK 700 Sensitive: C3 – Early Trials TAK 700 Sensitive : C3
AR overexpression AR overexpression	Prostate Cancer Prostate Cancer	enzalutamide Sensitive: C3 – Early Trials enzalutamide Sensitive : C3
AR overexpression AR overexpression	Triple Negative Breast Cancer Triple Negative Breast Cancer	enzalutamide Sensitive: C3 – Early Trials enzalutamide Sensitive : C3
AR overexpression AR overexpression	Estrogen Receptor Positive Breast Cancer Estrogen Receptor Positive Breast Cancer	RAD140 Sensitive: D – Preclinical RAD140 Sensitive : D
AR overexpression AR overexpression	Prostate Cancer Prostate Cancer	BMS-641988 Resistant: D – Preclinical BMS-641988 Resistant : D